3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Sarcoma
16
Osteosarcoma
10
Carcinosarcoma
9
Neoplasm Metastasis
8
Rhabdomyosarcoma
7
Neuroblastoma
7
Melanoma
6
Lymphoma, Non-Hodgkin
6
Endometrial Neoplasms
6
Wilms Tumor
5
Sarcoma, Ewing
5
Rhabdoid Tumor
5
Ovarian Neoplasms
5
Lung Neoplasms
5
Liposarcoma
5
Leiomyosarcoma
5
Histiocytosis, Langerhans-Cell
5
Hepatoblastoma
5
Gliosarcoma
5
Glioblastoma
5
Colorectal Neoplasms
5
Carcinoma, Renal Cell
5
Carcinoma, Non-Small-Cell Lung
5
Carcinoma, Hepatocellular
5
Sarcoma, Kaposi
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Medulloblastoma
4
Histiocytoma, Malignant Fibrous
4
Glioma
4
Ependymoma
4
Interventions
regorafenib
2
Doxorubicin
2
Cyclophosphamide
2
Cisplatin
2
tislelizumab
1
tazemetostat
1
sodium thiosulfate
1
entinostat
1
alanosine
1
X-Rays
1
Tamoxifen
1
Specimen Handling
1
Radiotherapy
1
Platinum
1
Magnetic Resonance Spectroscopy
1
Hyperthermic Intraperitoneal Chemotherapy
1
Fentanyl
1
Etoposide
1
Erlotinib Hydrochloride
1
Cytoreduction Surgical Procedures
1
Clinical Trials, Phase II as Topic
1
Celecoxib
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Specimen Handling
×
Sarcoma
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled